A Phase 1 Open-Label, Randomised Study of the Safety, Tolerability and Brain Delivery of Intranasal INB-01 in Healthy Adult Participants
100 Clinical Results associated with InnarisBio, Inc.
0 Patents (Medical) associated with InnarisBio, Inc.
100 Deals associated with InnarisBio, Inc.
100 Translational Medicine associated with InnarisBio, Inc.